China's Latest Cybersecurity Proposal Could Heighten Scrutiny On Device, Drug Industries
Executive Summary
Medtech and biopharma are among key information infrastructure industries likely subject to additional security and reporting obligations under draft legislation, adding costs and even potentially causing business disruptions, legal experts say.
You may also be interested in...
Is Enough Being Done About Cybersecurity In The EU? Contradictory Views Raise Regulatory Questions
A recent report from the UK Royal Academy of Engineering suggests that more efforts are needed to ensure cybersecurity protections for medical devices. But a key European industry trade association says that cybersecurity is adequately addressed from a regulatory standpoint in the EU.
China Cybersecurity Law Catches Pharma Firms Unawares
China’s first cyber security law came into effect in June, but some pharma companies do not realize they need to comply.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.